Gene Expression Assays for Early-Stage Hormone Receptor-Positive Breast Cancer: Understanding the Differences.

JNCI Cancer Spectr · 2017 · PMC6649766 · PMID 31360834

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Using “leave-one-out” cross-validation, they were able to generate a 70-gene assay with a highly significant odds ratio of 15 for freedom from distant recurrence in the low-risk group.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.